- In April 2024, the Government of Nigeria, in collaboration with the Global Fund, launched an expanded nationwide distribution campaign of ACTs and rapid diagnostic tests (RDTs), aiming to reach over 80% of malaria-endemic communities. This large-scale intervention targets improved early detection and treatment access, especially for vulnerable groups such as children under five and pregnant women. The initiative highlights Nigeria’s ongoing commitment to reducing malaria-related mortality and reinforces its leadership role in Africa’s malaria response
- In March 2024, Novartis announced the renewal of its commitment to malaria elimination in Africa by pledging the supply of 100 million doses of pediatric ACTs over the next five years. The company also introduced a next-generation antimalarial compound currently in late-stage development to combat emerging drug resistance. This initiative underlines the growing role of pharmaceutical innovation in addressing persistent treatment challenges across the region
- In February 2024, Uganda’s Ministry of Health, supported by the U.S. President’s Malaria Initiative (PMI), launched an integrated community-based malaria management program. The program deploys trained community health workers to conduct door-to-door testing and administer ACTs, improving access in rural areas with limited health infrastructure. This approach strengthens grassroots-level treatment delivery and demonstrates a scalable model for high-burden countries
- In January 2024, the Kenya Medical Research Institute (KEMRI), in partnership with PATH and GSK, began a phased introduction of the RTS,S/AS01 malaria vaccine in high-transmission counties. The rollout focuses on children under five, complementing existing drug-based interventions and marking a major step forward in combining vaccination with traditional treatment strategies. The development showcases Kenya’s commitment to integrated malaria control efforts
- In December 2023, South Africa’s National Department of Health announced the successful expansion of its Elimination 8 (E8) cross-border malaria strategy. The initiative includes enhanced surveillance, real-time data sharing, and targeted treatment protocols in border regions. By strengthening regional collaboration with neighboring countries such as Mozambique and Zimbabwe, South Africa is advancing toward malaria elimination and setting an instance for regional control frameworks
